Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Prostatic Neoplasms 3Breast Neoplasms 3Pancreatic Neoplasms 2Neuroblastoma 2Melanoma 2Breast Neoplasms, Male 2Renal Insufficiency, Chronic 1Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Nivolumab 146Ipilimumab 137pembrolizumab 122Cyclophosphamide 78Interleukin-2 69aldesleukin 63Temozolomide 46trametinib 37Radiosurgery 37Vemurafenib 36fludarabine 34Biopsy 34dabrafenib 33Radiotherapy 33Blood Specimen Collection 31fludarabine phosphate 30sargramostim 27Bevacizumab 27Introns 23Dacarbazine 22Magnetic Resonance Spectroscopy 21Specimen Handling 20CTLA-4 Antigen 20encorafenib 19cobimetinib 19binimetinib 19Paclitaxel 19Granulocyte-Macrophage Colony-Stimulating Factor 19Cisplatin 17incomplete Freund's adjuvant 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Melanoma × saponin QA-21V1 × Clear all
NCT00003224 2014-11-20

Vaccine Therapy in Treating Patients With Metastatic Melanoma

University of Virginia

Phase 1 Completed
22 enrolled 14 charts
Dermatologic

Melanoma

NCT00003362 2013-06-25

Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡